semaglutide for liver Landmark Study Finds Effectively Treats Serious Disease : ScienceAlert Semaglutide Reduces Liver Fibrosis and
Description
Extrapolation is scientifically defensible but has generated litigation
Another phase 2 study in subjects with poorly controlled T2D reveals mean HbA1c reduction of 1.4%, 1.7%, and 1.6% over 20 weeks at doses of 3.0 mg, 4.5 mg, and 6.0 mg, respectively, compared to a reduction of 1.4% with dulaglutide 1.5 mg and increase of 0.03% in the placebo group
But the larger peak was something entirely new
2020;12 doi: 10.7759/cureus.11735
What are the common side effects of Wegovy
Studies show 2030% of rapid weight-loss patients experience telogen effluvium, triggered by metabolic stress rather than medication toxicity
